Streetbeat News

Stock Prices

LITT

Logistics Innovation Technologies confirmed the redemption of shares at approximately $10.26 per share, before accounting for taxes and dissolution expenses.

Portfolio Pulse from Charles Gross

June 06, 2023 | 8:18 pm

UNP

A large bearish position on Union Pacific (NYSE:UNP) has been spotted, with 91% of big-money traders showing bearish sentiment. Whales have been targeting a price range of $197.5 to $260.0 for Union Pacific over the last 3 months.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 8:16 pm

BASE

Couchbase (NASDAQ:BASE) reported Q1 earnings with an EPS of $-0.27, beating estimates by 15.62%. Revenue increased by $6.14 million YoY. The company has a history of beating EPS estimates and experiencing share price increases.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 8:15 pm

LMNR

Limoneira (NASDAQ:LMNR) reported Q2 earnings with a 10.53% beat on estimated EPS at $0.21 and revenue up $1.32 million YoY. Last quarter, the company missed EPS estimates by $0.18, followed by a 4.53% increase in share price.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 8:15 pm

JFBR

Jeffs' Brands (JFBR) has received a Nasdaq minimum bid price notification, giving the company until November 27, 2023, to regain compliance with the minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:14 pm

COGT

Cogent Biosciences announced a proposed $125 million public offering of its common stock. The proceeds will be used for general corporate purposes, including research and development.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:13 pm

CVGW

Calavo Growers (CVGW) expects avocado volumes in the fiscal second half to exceed prior year levels, indicating a potential increase in revenues.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:12 pm

YEXT

Yext forecasts FY24 adjusted EPS of $0.28-$0.29, beating the estimated $0.21, and revenue of $404M-$407M, surpassing the estimated $403.57M.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:11 pm

RNAZ

TransCode Therapeutics has announced positive preclinical results for its lead candidate TTX-MC138 in treating glioblastoma. The company's stock, RNAZ, may be impacted by this news.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2023 | 8:10 pm

PLAY

Dave & Buster's (NASDAQ:PLAY) reported Q1 earnings with an EPS of $1.45, beating estimates by 16.94%. Revenue was up $146.20 million YoY. The company has a history of beating EPS estimates and experiencing share price increases.

Portfolio Pulse from Benzinga Insights

June 06, 2023 | 8:10 pm